Oncogenes and Mammary Carcinogenesis

作者: Maria Luisa Veronese , Florencia Bullrich , Carlo M. Croce

DOI: 10.1007/978-1-59259-699-7_7

关键词:

摘要: Breast cancer is the most common malignancy among women in United States, accounting for nearly 32% ofall cancers and 20% deaths (1). a multifactorial disease, several factors are thought to influence risk of breast development, including geography, radiation exposure, reproductive family history. A history constitutes major factor, although familial accounts only 5% all cases Although declined by between 1989 1992 (2), incidence expected increase 2–3% annually (1), efforts decrease mortality significantly, new therapeutic approaches early diagnosis, have been relatively unsuccessful. One critical determining approach cancer, along with presence or absence lymph node metastasis, estrogen progesterone receptor (ER PR) status tumor. Indeed, ER- and/or PR-positive tumors found be more likely respond endocrine therapy associated better prognosis An understanding genetic changes involved its biologic behavior, possible interactions hormones oncogenes tumor suppressor genes, will undoubtedly aid design therapies as well prevention diagnosis this disease.

参考文章(117)
David Berd, Masayoshi Shimizu, Hirokazu Nagai, Carol L. Shields, Kay Huebner, Jerry A. Shields, Arun D. Singh, Michael Mastrangelo, Masataka Ohta, Carlo M. Croce, Debora Rasio, Rarity of Somatic and Germline Mutations of the Cyclin-dependent Kinase 4 Inhibitor Gene, CDK4I, in Melanoma Cancer Research. ,vol. 54, pp. 5269- 5272 ,(1994)
Sherr Cj, Shapiro Dn, Valentine M, Khatib Za, Matsushime H, Look At, Coamplification of the CDK4 Gene with MDM2 and GLI in Human Sarcomas Cancer Research. ,vol. 53, pp. 5535- 5541 ,(1993)
Ivan Bièche, Rosette Lidereau, Marie-Hélène Champème, A Tumor Suppressor Gene on Chromosome 1p32-pter Controls the Amplification of MYC Family Genes in Breast Cancer Cancer Research. ,vol. 54, pp. 4274- 4276 ,(1994)
L Pylkkänen, S Toikkanen, H Joensuu, Bcl-2 protein expression and long-term survival in breast cancer. American Journal of Pathology. ,vol. 145, pp. 1191- 1198 ,(1994)
Carlo M. Croce, Peter C. Nowell, Molecular Basis of Human B Cell Neoplasia RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding. ,vol. 65, pp. 116- 126 ,(1985) , 10.1007/978-1-4613-2583-3_10
Carlo M. Croce, Aruna Basu, Subrata Haldar, Bcl2 Is the Guardian of Microtubule Integrity Cancer Research. ,vol. 57, pp. 229- 233 ,(1997)
M. A. Christine Pratt, Christine Teixeira, John C. Reed, Estrogen Promotes Chemotherapeutic Drug Resistance by a Mechanism Involving Bcl-2 Proto-Oncogene Expression in Human Breast Cancer Cells Cancer Research. ,vol. 55, pp. 3902- 3907 ,(1995)
Qi-Long Lu, Paul Abel, Christopher S Foster, El-Nasir Lalani, bcl-2 : role in epithelial differentiation and oncogenesis Human Pathology. ,vol. 27, pp. 102- 110 ,(1996) , 10.1016/S0046-8177(96)90362-7
C. E. Gauwerky, F. G. Haluska, Y. Tsujimoto, P. C. Nowell, C. M. Croce, Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 8548- 8552 ,(1988) , 10.1073/PNAS.85.22.8548
Bruno Amati, Hartmut Land, Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Current Opinion in Genetics & Development. ,vol. 4, pp. 102- 108 ,(1994) , 10.1016/0959-437X(94)90098-1